Sharon Bio-Medicine Ltd

BSE : SHARONBIO28 Mar 2019
Pharmaceuticals
0.00 (0.00%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Sharon Bio-Medicine Ltd
Sharon Bio-Medicine Ltd
Pharmaceuticals
BSE : SHARONBIO28 Mar 2019
0.00 (0.00%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All
No Data Found

Sharon Bio-Medicine Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
-41.85%
Upper Circuit
Lower Circuit
P/E TTM
2.01
P/B Ratio
-0.07
Traded Value(Cr)
0.00
EPS TTM
1.6
Book value
Dividend
0.00%

Invest in Sharon Bio-Medicine Ltd at ZERO Brokerage for 30 days

Price Performance

-15.30 %
1 Wk
-8.29 %
1 M
-38.27 %
3 M
-41.85 %
1 Y
-35.80 %
YTD

Traded Volume Movement

Technical Details

Support 3
4
Support 2
4
Support 1
4
Pivot Point :
4
Resistance 1
4
Resistance 2
4
Resistance 3
4

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Sharon Bio-Medicine Ltd
₹3.21(0.00/0.00%)
3.21+0.0038.18-41.852.01-0.07
Bliss GVS Pharma Ltd
₹149.70(-3.90/-2.54%)
149.70-3.901,577.3922.8619.441.54
Astrazeneca Pharma India Ltd
₹7,639.45(+45.90/0.60%)
7,639.45+45.9019,098.6312.94148.3728.11
Amrutanjan Health Care Ltd
₹659.70(-11.10/-1.65%)
659.70-11.101,907.2311.8340.136.40
Abbott India Ltd
₹29,796.40(+694.45/2.39%)
29,796.40+694.4563,317.353.7547.4517.98
53.24+1.69408.00-21.8746.309.05

About Sharon Bio-Medicine Ltd

Sharon Bio-Medicine Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 38.18 crores. It has reported a sales of Rs. 43 crores and a net profit of Rs. 1.81 crores for the quarter ended December 2018. The company management includes Savita Gowda, Savita Gowda,Lalit Misra,Nivedita Patil,Harish Palecanda (Sharon Bio-Medicine Ltd) among others.
Chairman
Savita Gowda
Registered office
W-34  34/1 MIDC,Taloja,Raigad,Maharashtra,410208
FAX :
Background
Incorporation Year1989
Face Value₹2
Market Lot1

Latest News

Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday

The Indian stock market ended lower for the third straight session, with the Nifty 50 index down 43 points at 23,559, amid weak global market sentiments. Sumeet Bagadia, Executive Director at Choice Broking, recommends buying 📌HDFC Life, 📌UltraTech Cement, and 📌Tech Mahindra, with targets of ₹700, ₹12,800, and ₹1,875, respectively.
08 Feb 2025 | 03:11 PM

These smallcaps have surged up to 26% as broader indices see muted gains

The broader indices performed in line with the main indices, which witnessed volatility amid mixed quarterly earnings, continued FII selling, mixed global markets due to uncertain tariff policies by the US President and rate cut by RBI in almost five years. BSE Smallcap index ended marginally in the green, breaking a 4-week losing streak, while BSE Midcap and Largecap indices ended higher.
08 Feb 2025 | 03:03 PM

Zaggle ups FY25 revenue guidance to 58-63%, profit increases 33% YoY

Zaggle Prepaid Ocean Services reported a 69% year-on-year surge in revenue, reaching  ₹336.4 crore in Q3FY25. Net profit grew to  ₹20.2 crore during the quarter, marking a 33% year-on-year increase. The revenue surge was driven by a 54% increase in programme fees from its expanded prepaid and credit card portfolio and an 86% jump in Propel revenue, fuelled by heightened festive season spending.
08 Feb 2025 | 12:11 PM

BHEL secures ₹8,000 crore thermal power project from Mahagenco

State-owned Bharat Heavy Electricals Ltd. (BHEL) has received a Letter of Award (LoA) worth approximately ₹8,000 crore from Maharashtra State Power Generation Company Ltd (Mahagenco). The LoA is for 2x660 MW BTG package of Koradi Thermal Power Station, the company said in an exchange filing. The BTG package includes supply of equipment, erection and commissioning and civil works.
08 Feb 2025 | 12:11 PM

Zaggle ups FY25 revenue guidance to 58-63%, profit increases 33% YoY

Zaggle Prepaid Ocean Services reported a 69% year-on-year surge in revenue, reaching  ₹336.4 crore in Q3FY25. Net profit grew to  ₹20.2 crore during the quarter, marking a 33% year-on-year increase. The revenue surge was driven by a 54% increase in programme fees from its expanded prepaid and credit card portfolio and an 86% jump in Propel revenue, fuelled by heightened festive season spending.
08 Feb 2025 | 12:11 PM

How to buy Sharon Bio-Medicine Ltd shares on nse?

To buy Sharon Bio-Medicine Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Sharon Bio-Medicine Ltd share price today?

The Sharon Bio-Medicine Ltd shares price on nse is Rs.3.21 today.

What is the market cap of Sharon Bio-Medicine Ltd shares on BSE ?

The company has a market capitalization of Rs.38.18Cr

What is the PE & PB ratio of Sharon Bio-Medicine Ltd shares ?

PE is 2.01 and PB is -0.07

What is the 52 Week High and Low of Sharon Bio-Medicine Ltd shares?

Sharon Bio-Medicine Ltd stock price high: Rs.3.3 Sharon Bio-Medicine Ltd stock price low: Rs.0
Click here to see your activities